Software developer MindwaysCT said it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market a new version of its software that acquires bone mineral density measurements from CT images.
The latest version of the company's quantitative CT (QCT) software works by using a previously acquired calibration scan to convert a CT image into bone mineral density values, MindwaysCT said.
The software can be applied to any non-intravenous-contrast abdominal or pelvic CT scan, reducing patient exposure to additional radiation. It can even be used to interrogate a PACS archive to find CT scans of appropriate patient groups, MindwaysCT said.
The software is particularly useful when applied to CT colonography (CTC) scans, because the over-50 patient population that undergoes colorectal cancer screening is also at high risk for osteoporosis, according to the company.